Thanks - appreciate the interest as I'm interested too in what others think.
Here's some of my thoughts in no particular order:
1. I'm frustrated with the fact the letter has not yet arrived.
2. If the letter does not have at least high level financial info, my frustration will grow. If they have the AMEX filing ready to go, then they have financial info they could share so I would not understand the reasoning for not sharing it. As we have seen with comparables, in the medical products industry, even sharing horrible financials allows the shares to trade higher.
3. I continue to use and be amazed by their products. I recently ordered more ZingiberRx - still can't believe how well it works - and I'm saying that as a consumer, not as an investor.
4. From the few conversations I have had with people at the company (mostly last year) I think the management is an experienced, focused team. I think they are very much concentrating on the long term strategy and not willing to sacrifice with short term activities. But it's hard for all of us including myself to remember this because we want to hear constant updates.
5. Clearly the company is making some decent money because they have gone for a long time without the need to do serious dilution at this low stock price. This HAS TO MEAN they are not burning through cash. There is no other way to interpret the lack of dilution. So this further supports my beliefs that they have decent financials and have some significant sales - otherwise they would have run out of money a long time ago. This is really the most important point... But stock price will not trade higher until market gets confirmation of this fact.
Of course I'm saying this without seeing actual dilution numbers right.. But if they are quietly diluting to either management or other investors, it means they have financials to back it up and get people to invest further. Otherwise they'd be tapping general market with their equity.
6. I personally believe they are forging further agreements with pharm companies. I think they are just continuing to be very quiet about it (again - long term view vs. short term view). I could be totally wrong here, but I think this is more supportive of the fact they haven't needed to raise more cash via equity. I think they are making plenty of money on therapy alone. I believe Abbott agreement is still ongoing.
So bottom line is, I think the fundamentals are all still very supportive of an incredible investment. We just have to keep patient for now and watch what happens this year. There are a ton of dynamics in play for this year namely the US economy. But medical co's historically do very well in slower economic times because people focus on spending money on what counts, and not so much on luxury. I will be baffled if they don't release financials either in the letter or within the next month. I think long term view here is optimal.
Would like to hear other thoughts on any of these points as well.
